Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate

被引:152
作者
Furuhashi, M
Sjöblom, T
Abramsson, A
Ellingsen, J
Micke, P
Li, H
Bergsten-Folestad, E
Eriksson, U
Heuchel, R
Betsholtz, C
Heldin, CH
Östman, A
机构
[1] Ludwig Inst Canc Res, Uppsala Branch, SE-751 Uppsala, Sweden
[2] Univ Gothenburg, Dept Biochem Med, Gothenburg, Sweden
[3] Ludwig Inst Canc Res, Stockholm Brach, S-10401 Stockholm, Sweden
关键词
D O I
10.1158/0008-5472.CAN-03-1489
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Platelet-derived growth factor (PDGF) receptor signaling participates in different processes in solid tumors, including autocrine stimulation of tumor cell growth, recruitment of tumor stroma fibroblasts, and stimulation of tumor angiogenesis. In the present study, the B16 mouse melanoma tumor model was used to investigate the functional consequences of paracrine PDGF stimulation of host-derived cells. Production of PDGF-BB or PDGF-DD by tumor cells was associated with an increased tumor growth rate. Characterization of tumors revealed an increase in pericyte abundance in tumors derived from B16 cells producing PDGF-BB or PDGF-DD. The increased tumor growth rate associated with PDGF-DD production was not seen in mice expressing an attenuated PDGF beta-receptor and was thus dependent on host PDGF beta-receptor signaling. The increased pericyte abundance was not associated with an increased tumor vessel density. However, tumor cell apoptosis, but not proliferation, was reduced in tumors displaying PDGF-induced increased pericyte coverage. Our findings thus demonstrate that paracrine PDGF production stimulates pericyte recruitment to tumor vessels and suggest that pericyte abundance influences tumor cell apoptosis and tumor growth.
引用
收藏
页码:2725 / 2733
页数:9
相关论文
共 49 条
[1]   Analysis of mural cell recruitment to tumor vessels [J].
Abramsson, A ;
Berlin, Ö ;
Papayan, H ;
Paulin, D ;
Shani, M ;
Betsholtz, C .
CIRCULATION, 2002, 105 (01) :112-117
[2]   Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors [J].
Abramsson, A ;
Lindblom, P ;
Betsholtz, C .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (08) :1142-1151
[3]  
[Anonymous], 1988, LAB ANIM-UK, V22, P195
[4]   PDGF-BB MODULATES ENDOTHELIAL PROLIFERATION AND ANGIOGENESIS IN-VITRO VIA PDGF BETA-RECEPTORS [J].
BATTEGAY, EJ ;
RUPP, J ;
IRUELAARISPE, L ;
SAGE, EH ;
PECH, M .
JOURNAL OF CELL BIOLOGY, 1994, 125 (04) :917-928
[5]   Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal [J].
Benjamin, LE ;
Golijanin, D ;
Itin, A ;
Pode, D ;
Keshet, E .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :159-165
[6]   Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors [J].
Bergers, G ;
Song, S ;
Meyer-Morse, N ;
Bergsland, E ;
Hanahan, D .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (09) :1287-1295
[7]   PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor [J].
Bergsten, E ;
Uutela, M ;
Li, XR ;
Pietras, K ;
Östman, A ;
Heldin, CH ;
Alitalo, K ;
Eriksson, U .
NATURE CELL BIOLOGY, 2001, 3 (05) :512-516
[8]  
Buchdunger E, 1996, CANCER RES, V56, P100
[9]   Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors [J].
Cao, RH ;
Bråkenhielm, E ;
Li, XR ;
Pietras, K ;
Widenfalk, J ;
Östman, A ;
Eriksson, U ;
Cao, YH .
FASEB JOURNAL, 2002, 16 (12) :1575-1583
[10]   Glivec (ST1571, Imatinib), a rationally developed, targeted anticancer drug [J].
Capdeville, R ;
Buchdunger, E ;
Zimmermann, J ;
Matter, A .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :493-502